MEDIQ 
By
Financial highlights
Net sales
Declined 4% to € 625.1 million; growth from
acquisitions at Direct & Institutional offset by a decrease
in sales at Pharmacies Netherlands and Pharmacies
Poland.
EBITA from ordinary activities
Decreased 22% to € 21.9 million; mainly as a result
of the declining sales from pharmaceuticals and the
restructuring provision (€ 3.1 million) at Pharmacies
Netherlands.
Net result
Amounted to € 0.9 million due to the impairment of
wholesaling assets at Pharmacies Netherlands and lower
EBITA from ordinary activities.
Cash flow
Cash flow from operating activities of € 57.0
million.
Outlook 2012
Expected EBITA between € 88 million and € 91
million. The downward adjustment relative to the earlier
outlook (€ 111-116 million) is caused mainly by the
restructuring provision and the impairment of wholesaling
assets at Pharmacies Netherlands.
Operational highlights
Direct & Institutional
